Online / Physical Event

International Conference on

Infectious Diseases

Theme: Most Relevant Research on Novel Coronavirus, prevention and control

Event Date & Time

Event Location

London, UK

Program Abstract Registration Awards 2020

18 years of lifescience communication

447588772948

Performers / Professionals From Around The Globe

Tracks & Key Topics

Infectious Diseases Conference 2021

About Conference

17th Edition of International Conference on Infectious Diseases will provide all the attendees, the opportunity to network with experts, present their research findings to an international audience and notify the latest scientific developments from world’s eminent speakers and contribute to various discussions that will shape future health policies and a proper patient care all around the world.

The Conference will have a mix of lectures of keynote addresses, panel discussions, case discussions, current reports of scientific progress featured in oral abstracts and posters. The chosen topics will be of great benefit to practicing clinicians and academicians in the field of infectious diseases, medicine, microbiology, epidemiology, public health, critical care, pulmonology, pharmacology, pathology, pharmacy, nursing, and clinical research. This conference offers an opportunity for faculty, postgraduates, fellows, residents, and undergraduates to present their work, learn and network with the experts. The Infection Control conference hosting presentations from editors of eminent refereed journals, renowned and active investigators and decision makers in the field of infectious diseases, microbiology, immunology, infection control and prevention. Infection control 2019 Organizing Committee also invites young investigators at each and every career stage to submit abstracts reporting their latest scientific researches in oral and poster sessions

 

 

 

 

Session And Tracks

Track 1: Coronavirus (Covid-19)

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It was first identified in December 2019 in Wuhan, China, and has resulted in an ongoing pandemic. The first case may be traced back to 17 November 2019. As of 10 June 2020, more than 7.24 million cases have been reported across 188 countries and territories, resulting in more than 411,000 deaths. More than 3.37 million people have recovered. Common symptoms include fever, cough, fatigue, shortness of breath, and loss of smell and taste. While the majority of cases result in mild symptoms, some progress to acute respiratory distress syndrome (ARDS) likely precipitated by a cytokine storm, multi-organ failure, septic shock, and blood clots

Track 2: Global Infectious Diseases

Globalization, the flow of information, goods, capital, and people across political and geographic boundaries, allows infectious diseases to rapidly spread around the world, while also allowing the alleviation of factors such as hunger and poverty, which are key determinants of global health. The spread of diseases across wide geographic scales has increased through history. Early diseases that spread from Asia to Europe were bubonic plague, influenza of various types, and similar infectious diseases.

Track 3: Research on Medicine and Vaccine for covid-19

A COVID-19 vaccine is a hypothetical vaccine against coronavirus disease 2019 (COVID‑19). Although no vaccine has completed clinical trials, there are multiple efforts in progress to develop such a vaccine. In February 2020, the World Health Organization (WHO) said it did not expect a vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus, to become available in less than 18 months. Previous attempts to develop a vaccine against the coronavirus diseases, SARS and MERS, established considerable knowledge about the structure and function of coronaviruses – which accelerated rapid development during early 2020 of varied technology platforms for a COVID-19 vaccine

Track 4: Host Microbial Genetics

Microbial genetics is a subject area within microbiology and genetic engineering. Microbial genetics studies microorganisms for different purposes. The microorganisms that are observed are bacteria, and archaea. Some fungi and protozoa are also subjects used to study in this field. The studies of microorganisms involve studies of genotype and expression system. Genotypes are the inherited compositions of an organism. (Austin, "Genotype," n.d.) Genetic Engineering is a field of work and study within microbial genetics. The usage of recombinant DNA technology is a process of this work

Track 5: Pediatric Infectious Diseases and Allergy

Paediatric infectious diseases/ childhood infectious diseases are the infectious diseases which are caused in children of diverse age groups. Infection from mother to foetus, in just born babies and children is growing danger. The death rates are increasing due to infections. The epidemiological features of congenital and neonatal diseases due to bacterial, viral, vector-borne infections despite become more threat.

Track 6: Zoonotic Diseases

A zoonosis plural zoonoses, or zoonotic diseases is an infectious disease caused by a pathogen (an infectious agent, such as a bacterium, virus, parasite or prion) that has jumped from a non-human animal (usually a vertebrate) to a human. Typically, the first infected human transmits the infectious agent to at least one other human, who, in turn, infects others. Major modern diseases such as Ebola virus disease and salmonellosis are zoonoses

Track 7: Clinical Immunology

Immunology is a branch of biology that covers the study of immune systems in all organisms. Immunology charts, measures, and contextualizes the physiological functioning of the immune system in states of both health and diseases; malfunctions of the immune system in immunological disorders (such as autoimmune diseases, hypersensitivities, immune deficiency, and transplant rejection

Track 8: Anti-microbial agents

Antimicrobials are the drugs used in the treatment and prevention of bacterial infections like strep throat, urinary tract infections and tuberculosis. They may either completely kill or inhibit the growth of bacteria. Few antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viral diseases such as the common cold or influenza and their inappropriate may allow the emergence of resistant organisms.

Track 9: Pneumococci and Pneumococcal Diseases

A pneumococcal infection is an infection caused by the bacterium Streptococcus pneumoniae, which is also called the pneumococcus. S. pneumoniae is a common member of the bacterial flora colonizing the nose and throat of 5–10% of healthy adults and 20–40% of healthy children. However, it is also a cause of significant disease, being a leading cause of pneumonia, bacterial meningitis, and sepsis. The World Health Organization estimate that in 2005 pneumococcal infections were responsible for the death of 1.6 million children worldwide.

Track 10: Clinical Microbiology and Infectious Diseases

Clinical microbiology, the large subset of microbiology that is applied to medicine, is a branch of medical science concerned with the prevention, diagnosis and treatment of infectious diseases. In addition, this field of science studies various clinical applications of microbes for the improvement of health. There are four kinds of microorganisms that cause infectious disease: bacteria, fungi, parasites and viruses, and one type of infectious protein called prion.

Track 11: Animal Infectious Diseases

The viruses of vertebrates are informally distinguished between those that primarily cause infections of humans and those that infect other animals. The two fields of study are called medical (or clinical) virology and veterinary virology respectively. Although not the first viruses to be discovered and characterized, those that cause infections of humans are the most studied. Different viruses can infect all the organs and tissues of the body and the outcomes range from mild or no symptoms, to life-threatening diseases. Humans cannot be infected by plant or insect viruses.

Track 12: Microbial Genetics and Bacteriology

Microbial genetics is a subject area within microbiology and genetic engineering. Microbial genetics studies microorganisms for different purposes. The microorganisms that are observed are bacteria, and archaea. Some fungi and protozoa are also subjects used to study in this field. The studies of microorganisms involve studies of genotype and expression system. Genotypes are the inherited compositions of an organism. Genetic Engineering is a field of work and study within microbial genetics. The usage of recombinant DNA technology is a process of this work.

Track 13: Environmental Infectious Diseases

Environmental diseases are diseases that can be directly attributed to environmental factors (as distinct from genetic factors or infection). Apart from the true monogenic genetic disorders, environmental diseases may determine the development of disease in those genetically predisposed to a particular condition. Stress, physical and mental abuse, diet, exposure to toxins, pathogens, radiation, and chemicals found in almost all personal care products and household cleaners are possible causes of a large segment of non-hereditary disease.

Track 14: Air borne Infections

Airborne diseases include any that are caused via transmission through the air. Many airborne diseases are of great medical importance. The pathogens transmitted may be any kind of microbe, and they may be spread in aerosols, dust or liquids. The aerosols might be generated from sources of infection such as the bodily secretions of an infected animal or person, or biological wastes such as accumulate in lofts, caves, garbage and the like. Such infected aerosols may stay suspended in air currents long enough to travel for considerable distances; sneezes, for example, can easily project infectious droplets the full length of a bus

Track 15: HIV/AIDS

Human Immunodeficiency Virus damages the immune system. The Untreated HIV contaminates and damages CD4 cells. Thereafter HIV kills more and more CD4 cells, due to which body is bound to get different sorts of diseases and malignant growths. HIV is generally transmitted through organic liquids that incorporates blood, breast milk, semen, vaginal and rectal liquids. The infection generally does not spread through air, water or through easy-going contact

Track 16: Emerging and Non-Emerging Diseases

An emerging infectious disease (EID) is an infectious disease whose incidence has increased recently (in the past 20 years) and could increase soon. Such diseases do not respect national boundaries. The minority that can develop efficient transmission between humans can become major public and global concerns as potential causes of epidemics or pandemics. Their many impacts can be economic and societal, as well as clinical

Track 17: Antimicrobial/ Antibiotic/ Antibacterial Infections

Antimicrobials/antibiotics/ antibacterial are the drugs used in the treatment and prevention of bacterial infections like strep throat, urinary tract infections and tuberculosis. They may either completely kill or inhibit the growth of bacteria. Few antibiotics also possess antiprotozoal activity. Antibiotics are not effective against viral diseases such as the common cold or influenza and their inappropriate may allow the emergence of resistant organisms.

 

Track 18: Gastrointestinal Infections

Currently the Progression in the analysis and treatment of gastrointestinal diseases has been outstanding. Gastrointestinal infections are viral, bacterial, or parasitic infections that may cause gastroenteritis, an inflammation of the gastrointestinal tract involving both the stomach and the small intestine. Symptoms include diarrhoea, vomiting, and abdominal pain. Many Examination is going on new diagnostic strategies and novel therapeutic frameworks for gastroesophageal reflux sickness (GERD), pancreatic-biliary and post-surgical issues, Barrett's throat, neuroendocrine tumours, and gastrointestinal stromal tumours.

Track 19: Tuberculosis

Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. Tuberculosis generally affects the lungs but can also affect other parts of the body. Most infections show no symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those affected. The classic symptoms of active TB are a chronic cough with blood-containing mucus, fever, night sweats, and weight loss.

Track 20: Hepatitis Vaccine

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.

 

 

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!